BI

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Retrieved on: 
Monday, October 23, 2023
ARK, BI, AZ, History, The Coca-Cola Company, Cannes Lions International Festival of Creativity, Health, Acquisition, Ted Baker, Creativity, Fullerton Health Group, GSK, Panasonic, LEO, Association of Media in Digital Awards, Nightclub, Industrial design, Film industry, Takeda, Pfizer

By joining the OPEN Health executive leadership team, he will share this world-class, innovative approach throughout all of OPEN Health ’s global practices, including scientific communications, patient engagement, and HEOR and market access.

Key Points: 
  • By joining the OPEN Health executive leadership team, he will share this world-class, innovative approach throughout all of OPEN Health ’s global practices, including scientific communications, patient engagement, and HEOR and market access.
  • “Data-driven creativity is central to all our services, and Dom demonstrates an innate vision for driving it within OPEN Health.
  • He embodies a unique perspective and a freshness, seamlessly blending digital-first thinking with creative vision, but always with a commercial focus,” said Rob Barker, OPEN Health Group CEO.
  • Dom joined OPEN Health in 2021 through the acquisition of London-based creative agency ARK.

Spider Strategies Releases Spider Impact 5.6 with Enhanced Data Integration & Visualization

Retrieved on: 
Wednesday, October 25, 2023
BI, Business intelligence, Weather, Social media, Organizational founder, Organization, Data, Security, Impact, Multimedia, Third party, Division of Program Coordination, Planning, and Strategic Initiatives, Tableau, API, Intelligence, REST, Strategy, Logic, Video game, Retail, Management, Looker

ARLINGTON, Va., Oct. 25, 2023 /PRNewswire-PRWeb/ -- Spider Strategies, a leading provider of strategy execution software, today announced the release of Spider Impact 5.6, packed with new features that break down data silos and promote insight-driven performance.

Key Points: 
  • Spider Strategies launched Spider Impact 5.6, an update to its strategy execution software, emphasizing enhanced data accessibility and integration.
  • "Spider Impact turns your data into the fuel for executing big-picture strategy," said Scott O'Reilly, Cofounder of Spider Strategies.
  • Key capabilities introduced in Spider Impact 5.6 include:
    Import from REST APIs: Users can now pull data from any REST API into Spider Impact datasets.
  • For more information about Spider Impact or Spider Strategies, visit https://www.spiderstrategies.com
    View original content to download multimedia: https://www.prweb.com/releases/spider-strategies-releases-spider-impact-...

MAOR INVESTMENTS Announces the Closing of Its Second Fund at $180M, 1.8x the Size of MAOR I

Retrieved on: 
Friday, October 20, 2023
Finance, Professional Services, Other Technology, Technology, Asset Management, BI, Sport, SFDR, ESG, Pyramid Analytics, Heart, DPI, PRI, DevOps, Multimedia, Principles for Responsible Investment, Ecosystem, Association of British HealthTech Industries, Principle, Quantum machine learning, Investment, Socially responsible investing, Financial services

MAOR INVESTMENTS, a Luxembourg-based venture capital fund dedicated to Israeli technologies, is proud to announce the final closing of its second fund, MAOR II, at $180 million.

Key Points: 
  • MAOR INVESTMENTS, a Luxembourg-based venture capital fund dedicated to Israeli technologies, is proud to announce the final closing of its second fund, MAOR II, at $180 million.
  • This access emphasizes the differentiating positioning of the fund as « Bridge to Europe », reflecting MAOR INVESTMENTS’ unique value in the Israeli ecosystem.
  • By aligning its investments with ESG criteria and signing the Principles for Responsible Investment (PRI) for MAOR II, an Article 8 SFDR fund, MAOR INVESTMENTS is committed to investing responsibly.
  • The MAOR INVESTMENTS team sincerely thanks its investors, portfolio companies, team members and corporate partners for their precious support and collaboration.

Simpro accelerates digital transformation for the field services industry at the first annual Simprosium

Retrieved on: 
Tuesday, October 17, 2023
Commercial Building & Real Estate, Technology, Construction & Property, Landscape, Business, Professional Services, Software, Data Management, Residential Building & Real Estate, Connective tissue, Investment, Ecosystem, Modus operandi, API, City, BI, Xero, Video game, Mobile phone, SimPRO, Stripe

Also, the incorporation of ClockShark time tracking capabilities to the platform and new digital form enhancements were announced.

Key Points: 
  • Also, the incorporation of ClockShark time tracking capabilities to the platform and new digital form enhancements were announced.
  • Customer discussions centered around adaptability, highlighting how business leaders respond to change and how Simpro facilitates and drives these transformations.
  • "The Simprosium roadshow was all about meeting our customers and understanding what is top of mind for them,” said Gary Specter, CEO of Simpro.
  • Continuing to build a collaborative ecosystem where customers partner with Simpro to lead the way in innovation in the global trade service sector.

Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease

Retrieved on: 
Thursday, October 5, 2023
Cardiovascular disease, III, BMI, Type 2 diabetes, European Association for the Study of Diabetes, Hypertension, Obesity, Prevalence, A1C, Disease, Overweight, Principal, Conditional sentence, EASD, Phase, Appetite, Dyslipidemia, Chronic kidney disease, Obstructive sleep apnea, BI, Zealand Pharma, Boehringer Ingelheim, University college, Risk, Pharmaceutical industry, Electric motor, Dietary supplement, Diabetes

Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease

Key Points: 
  • Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
    SYNCHRONIZE-1 and SYNCHRONIZE-2 are global Phase III studies of survodutide (BI 456906) in people living with obesity and overweight without and with type 2 diabetes, respectively
    A third study, SYNCHRONIZE-CVOT, is a global, long-term cardiovascular safety study of survodutide in people living with obesity and overweight with cardiovascular disease, chronic kidney disease or with risk factors for cardiovascular disease
    Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or obesity.
  • The trial design builds upon learnings from Phase II, in which people living with overweight or obesity achieved up to 19 percent weight loss.1 The Phase III trials will soon open for recruitment.
  • SYNCHRONIZE-1 will enrol people without type 2 diabetes (A1C
  • The third study, SYNCHRONIZE-CVOT, is a Phase III trial that will enrol people with overweight or obesity with cardiovascular disease, chronic kidney disease, or risk factors for cardiovascular disease.

Codestone Group Appoints Darryl Sackett as New CEO to Spearhead Ambitious Growth Plan

Retrieved on: 
Monday, October 16, 2023
Cloud, SAP Business ByDesign, Azure, Microsoft, Acquisition, Customer experience, Snow, UK Finance, SAP, Tagetik, EPM, Finance, Financial management, Entrepreneurship, Wolters Kluwer, Growth, Software, Microsoft Power BI, SAP Business One, Oracle Cloud Enterprise Resource Planning, BI, SME, Application lifecycle management, ERP, Management, Crayon, Neopets

LONDON, Oct. 16, 2023 /PRNewswire/ -- In a landmark decision designed to propel its already robust growth trajectory, Codestone Group is thrilled to announce the appointment of Darryl Sackett as its new CEO.

Key Points: 
  • LONDON, Oct. 16, 2023 /PRNewswire/ -- In a landmark decision designed to propel its already robust growth trajectory, Codestone Group is thrilled to announce the appointment of Darryl Sackett as its new CEO.
  • Darryl joins Codestone from his recent stint as VP of Customer Experience and Value at Snow Software.
  • Darryl stated, "I'm excited to lead Codestone into its next phase of growth.
  • Codestone Group: For over 25 years, the Codestone Group has consistently pioneered modern Enterprise Resource Planning (ERP) and cloud database technologies.

Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease

Retrieved on: 
Thursday, October 5, 2023
Diabetes, Health, Pharmaceutical, Clinical Trials, Cardiology, BMI, European Association for the Study of Diabetes, Multimedia, Hypertension, Obesity, Prevalence, A1C, Ingelheim am Rhein, Disease, Overweight, Principal, Conditional sentence, EASD, Phase, Appetite, Dyslipidemia, Obstructive sleep apnea, BI, Zealand Pharma, Boehringer Ingelheim, University college, Pharmaceutical industry

Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or obesity.

Key Points: 
  • Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or obesity.
  • The trial design builds upon learnings from Phase II, in which people living with overweight or obesity achieved up to 19 percent weight loss.1 The Phase III trials will soon open for recruitment.
  • SYNCHRONIZE-1 will enroll people without type 2 diabetes (A1C
  • The third study, SYNCHRONIZE-CVOT, is a Phase III trial that will enroll people with overweight or obesity with cardiovascular disease, chronic kidney disease, or risk factors for cardiovascular disease.

Zuar Forges a Dynamic Partnership With ThoughtSpot in Their Quest to Revolutionize AI-Powered Analytics

Retrieved on: 
Thursday, October 12, 2023
Partnership, Senior, Machine learning, Value, AI, Organization, Worldwide, APJ, ThoughtSpot, BI, Video game, Retail, Online shopping, List of minor Hebrew Bible figures, L–Z

AUSTIN, Texas, Oct. 12, 2023 /PRNewswire-PRWeb/ -- Zuar, a leading provider of embedded analytics solutions, today announced their partnership with ThoughtSpot, the AI-Powered Analytics Company. Together, Zuar and ThoughtSpot will help joint customers remove the barriers that organizations face when delivering a modern data experience.

Key Points: 
  • Zuar Platform Helps ThoughtSpot Customers Maximize the Value of their Data, Launch Embedded Analytics Faster
    AUSTIN, Texas, Oct. 12, 2023 /PRNewswire-PRWeb/ -- Zuar, a leading provider of embedded analytics solutions, today announced their partnership with ThoughtSpot , the AI-Powered Analytics Company.
  • Together, Zuar and ThoughtSpot will help joint customers remove the barriers that organizations face when delivering a modern data experience.
  • Zuar extends our [ThoughtSpot's] capabilities to work with any data and to seamlessly integrate ThoughtSpot into new and existing workflows.
  • ThoughtSpot's two flagship offerings, ThoughtSpot Analytics and ThoughtSpot Everywhere , perfectly complement Zuar's solutions, Zuar Runner and Zuar Portal .

Visier Makes Big Moves at HR Tech, as Systemic HR Takes Center Stage and People Analytics Emerges as Core Intelligence for Modern Business

Retrieved on: 
Wednesday, October 11, 2023
Diamond, Benchmark, Embedded, Caesars Entertainment, Monster, Data science, Microsoft, Business, Python, SQL, Organization, Microsoft Teams, AI, Software as a service, API, GM, Human resource management, Growth, LAS, Slack, Das unsichtbare Visier, Korn Ferry, Workflow, Platform as a service, Workforce, Generative, Synthetic media, Kenexa, Systemic, Digital, UI, BI, Conference, Management, Retail, Business travel, Sales, Cryptocurrency, Insperity, Fernando Visier Segovia, Alpine, Paycor Stadium, VEE

VANCOUVER, BC and LAS VEGAS, Oct. 11, 2023 /PRNewswire/ -- Visier, the globally recognized leader in people analytics and workforce solutions for people-powered business, today made several important announcements which together signal a shift from people analytics as a specialized reporting and analysis discipline within HR departments to people analytics as a pervasive data strategy where trusted and secure workforce insights inform virtually every people-related decision and workflow.

Key Points: 
  • In his opening HR Tech keynote this week, globally recognized industry analyst, Josh Bersin, discussed "Systemic HR," citing Visier as "one of the most spectacular examples of generative AI in HR today."
  • Bersin describes Systemic HR as the bridging of disconnected silos across the specialized functions within HR, and also the silos separating HR from the business itself.
  • Until now, adoption and use of people analytics has been limited to those who are most comfortable with data and analytics.
  • We're also seeing the people analytics category shift from a fairly narrow and specialized HR concern, to what can only be described as core intelligence for the business writ large.

BI Anna Jaques Hospital RNs Cast Overwhelming Vote to Authorize Three-Day Strike In Effort to Attain a New Contract to Recruit and Retain the Staff Needed to Ensure Quality Patient Care

Retrieved on: 
Thursday, October 5, 2023
Multimedia, Hospital, Negotiation, RNS, Nursing, Frustration, Commonwealth, Employment, Merrimack Valley, Safety, Health, RN, Workplace, Lahey Health, AJH, Love, MNA, Legislature, BI, National Nurses United, Patient

NEWBURYPORT, Mass., Oct. 5, 2023 /PRNewswire/ -- The registered nurses at Beth Israel Lahey Anna Jaques Hospital (AJH), who are currently in contract talks with hospital management, cast an overwhelming "yes" vote (99 percent) yesterday authorizing their local union leaders to call a three-day strike should hospital executives continue to fail to address longstanding issues that currently affect their ability to deliver the best possible care to patients.

Key Points: 
  • "We are trying to provide the highest-quality care possible to the people of this community, at a hospital we love and want to see thrive.
  • We need AJH executives to finally listen to us, and then to work with us to find and implement appropriate solutions."
  • "We love our hospital and our community and will do everything possible to restore it to its former highest standards."
  • Loss of vital services for the community as promised by BI Lahey in its agreement to merge with the hospital.